Published in

Oxford University Press (OUP), Journals of Gerontology, Series A, 2021

DOI: 10.1093/gerona/glab046

Links

Tools

Export citation

Search in Google Scholar

Creating and validating a DNA methylation-based proxy for interleukin-6

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Background Studies evaluating the relationship between chronic inflammation and cognitive functioning have produced heterogeneous results. A potential reason for this is the variability of inflammatory mediators which could lead to misclassifications of individuals’ persisting levels of inflammation. DNA methylation has shown utility in indexing environmental exposures and could be leveraged to provide proxy signatures of chronic inflammation. Methods We conducted an elastic net regression of interleukin-6 (IL-6) in a cohort of 875 older adults (Lothian Birth Cohort 1936; mean age: 70 years) to develop a DNA methylation-based predictor. The predictor was tested in an independent cohort (Generation Scotland; n=7,028 [417 with measured IL-6], mean age: 51 years). Results A weighted score from 35 CpG sites optimally predicted IL-6 in the independent test set (Generation Scotland; R 2=4.4%, p=2.1x10 -5). In the independent test cohort, both measured IL-6 and the DNA methylation proxy increased with age (serum IL-6: n=417, β=0.02, SE=0.004 p=1.3x10 -7; DNAm IL-6 score: n=7,028, β=0.02, SE=0.0009, p<2x10 -16). Serum IL-6 did not associate with cognitive ability (n=417, β=-0.06, SE=0.05, p=0.19); however, an inverse association was identified between the DNA methylation score and cognitive functioning (n=7,028, β=-0.16, SE=0.02, pFDR<2x10 -16). Conclusions These results suggest methylation-based predictors can be used as proxies for inflammatory markers, potentially allowing for further insight into the relationship between inflammation and pertinent health outcomes.